Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Concomitant with MMRV and PCV in Toddlers
NCT00422292Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2006
- Primary completion
- Jan 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of meningococcal A conjugate vaccine in meningococcal meningitis (4 arms), sponsored by Sanofi. Primary endpoints: Measles, Mumps, Rubella, and Varicella (MMRV) Antibody Values and Geometric Mean Concentrations (GMCs) of Anti-Pneumococcal Antibodies. Started Dec 2006; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00422292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422292.